ZRO — BIOSENTA Cashflow Statement
0.000.00%
Last trade - 00:00- CA$2.81m
- CA$3.47m
- CA$0.00m
Annual cashflow statement for BIOSENTA, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.
2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | 2025 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.04 | -1.46 | -6.3 | -2.23 | -2.51 |
| Depreciation | |||||
| Non-Cash Items | 0.988 | 0.143 | 4.96 | 1.17 | 1.42 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.381 | 0.811 | 0.79 | 0.277 | 0.626 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -0.672 | -0.504 | -0.551 | -0.779 | -0.455 |
| Capital Expenditures | — | — | -0.016 | 0 | -0.026 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | — | — | -0.016 | 0 | -0.026 |
| Financing Cash Flow Items | 0.327 | 0.477 | 0.267 | -0.014 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.74 | 0.42 | 0.545 | 0.782 | 0.499 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.068 | -0.085 | -0.021 | 0.003 | 0.018 |